Home › Funds › Citigroup Inc › PHIO
Citigroup Inc position in PHIO
PHIO PHARMACEUTICALS CORP · Health Care
Latest position (Q2 2026)11.61K sh
Reported value held$11.89K
Portfolio Weight0.00%
First reportedQ1 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 1.00K | $1.00K | New |
| Q3 2023 | 917 | $1.38K | New |
| Q1 2026 | 1.02K | $1.25K | New |
| Q2 2026 | 11.61K | $11.89K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PHIO
- Geode Capital Management 114.57K sh · $117.44K · Q2 2026
- Vanguard Group 87.63K sh · $92.01K · Q4 2025
- Citadel Advisors 47.15K sh · $48.33K · Q2 2026
- Northern Trust Corp 27.77K sh · $28.46K · Q2 2026
- Two Sigma Investments 21.50K sh · $22.04K · Q2 2026
- Morgan Stanley 6.00K sh · $6.15K · Q2 2026
- UBS Group AG 5.39K sh · $5.52K · Q2 2026